Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iris Or Gabi Bincovich Insider Profile
4 Followers
Iris Or Gabi Bincovich, Executive at InnoCan Pharma, holds 4.94M shares in InnoCan Pharma (Ticker: INNPF).
Iris Or Gabi Bincovich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Iris Or Gabi Bincovich's holdings
Insider Roles
Executive
Roles that Iris Or Gabi Bincovich holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Iris Or Gabi Bincovich
Iris Or Gabi Bincovich's Trading History
List of latest transactions for each holding click on a transaction to see Iris Or Gabi Bincovich's performance on stock
You May Also Like
Iris Or Gabi Bincovich insider profile FAQ
What is the percentage of profitable transactions made by Iris Or Gabi Bincovich?
The percentage of profitable transactions made by Iris Or Gabi Bincovich is ―.
What is the average return per transaction made by Iris Or Gabi Bincovich?
The average return per transaction made by Iris Or Gabi Bincovich is ―.
What stocks does Iris Or Gabi Bincovich hold?
Iris Or Gabi Bincovich holds: INNPF stocks.
What was Iris Or Gabi Bincovich’s latest transaction?
Iris Or Gabi Bincovich latest transaction was an Uninformative Sell of ―.
What was Iris Or Gabi Bincovich's most profitable transaction?
Iris Or Gabi Bincovich’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Iris Or Gabi Bincovich's role in InnoCan Pharma?
Iris Or Gabi Bincovich's role in InnoCan Pharma is Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.